Cannabis stocks traded mostly in the green this week, as we got into earnings season.
“While there were a lot of companies reporting earnings, like Turning Point Brands who gave guidance of $422 million for 2021, I thought the biggest piece of data came from Pennsylvania
,” Debra Borchardt, editor-in-chief of Green Market Report, told Benzinga. “The state reported that in one year it had sold over $900 million in medical marijuana. This demonstrates the demand for cannabis in this state and bodes well for any future adult-use legalization. This is also a big number when one considers that the program has only just gotten underway.”
IM Cannabis Acquires Israel s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
ACCESSWIRE
With Israel
1 per Month), Panaxia s Online Platform to Support Patient Base Expansion
Acquisition Broadens IMC s Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness
Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMC s Premium and Super-Premium Canadian Indoor Production Portfolio
Adds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legalization
IM Cannabis Corp.: IM Cannabis Acquires Israel s Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand
1 per Month), Panaxia s Online Platform to Support Patient Base Expansion
Acquisition Broadens IMC s Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness
Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMC s Premium and Super-Premium Canadian Indoor Production Portfolio
Adds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legalization
Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021
USA - English
The revenues reflect growth of over 56% compared to the corresponding period the previous year and over 12% compared to Q4 2020 - consistent growth over 14 straight quarters
The revenues include income from exports of Panaxia products to Germany, which began at the end of Q4 2020; towards the end of Q1 2021, the company began commercial exports of its products to Cyprus
News provided by
Share this article
( Panaxia Israel ) (TASE: PNAX),
Israel s largest manufacturer of medical cannabis products, today announced its estimated revenues for the first quarter of 2021. According to Panaxia s estimates, its consolidated (unaudited) revenues for the first quarter of 2021 are expected to reach no less than 19 million.
Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.